EcoDrugPlus

Histone Deacetylase 8

Ensembl ID : ENSORLG00000009606
Gene Symbol: HDAC8
4 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSORLG00000013180
Gene Symbol: HCN4
1 Cross references
221 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSORLG00000009860
Gene Symbol: HCRTR2
4 Cross references
203 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSORLG00000002465
Gene Symbol: IKBKB
4 Cross references
199 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSORLG00000015584
Gene Symbol: INPP5D
4 Cross references
215 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSORLG00000018568
Gene Symbol: LOC101168764
3 Cross references
212 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSORLG00000017980
Gene Symbol: INSRA
4 Cross references
213 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSORLG00000014732
Gene Symbol: LOC101163560
4 Cross references
203 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSORLG00000008532
Gene Symbol: LOC101173298
4 Cross references
204 Possible Orthologues:

Integrin Alpha-5

Ensembl ID : ENSORLG00000011967
Gene Symbol: LOC101170341
3 Cross references
197 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSORLG00000003389
Gene Symbol: ITGB3A
4 Cross references
201 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSORLG00000004690
Gene Symbol: ITGB3B
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).